Rictor Antibody

Product Specs
ItemRictor Antibody - BSA Free
CompanyNovus Biologicals, a Bio-Techne Brand
Price $459.00Supplier Page View Company Product Page
Catalog NumberNB100-611
Concentration1.0 mg/ml
ApplicationsImmunoprecipitation,Western Blot
Quantity100 ul
ReactivityHuman
TargetRictor
Conjugate/TagUnconjugated
HostRabbit
FormatTris-Citrate/Phosphate (pH 7.0 - 8.0)
ImmunogenThe immunogen recognized by this antibody maps to a region between residues 1 and 50 of human Rapamycin-Insensitive Companion of mTOR using the numbering given in TrEMBL entry Q6R327 (GeneID 253260)
ClonalityPolyclonal
PurityImmunogen affinity purified
Research AreaCancer, mTOR Pathway
IsotypeIgG
NCBI Full Gene NameRPTOR independent companion of MTOR complex 2
NCBI Gene AliasesPIA, hAVO3, AVO3
Antibody TypePrimary Antibodies
StorageStore at 4C. Do not freeze

Available conjugates: Unconjugated

United States: 10771 E Easter Ave

Centennial, Colorado 80112

United States

Phone:
303-730-1950
888-506-6887

Email: novus@novusbio.com

(1) Regulation of mTOR complex 2 signaling in neurofibromatosis 2-deficient target cell typesMolecular cancer research : MCRMay 1, 2012James MF, Stivison E, Beauchamp R, Han S, Li H, Wallace MR, Gusella JF, Stemmer-Rachamimov AO, Ramesh V.

(2) Temsirolimus and rituximab in patients with relapsed or refractory mantle cell lymphoma: a phase 2 studyThe Lancet. OncologyApril 1, 2011Ansell SM, Tang H, Kurtin PJ, Koenig PA, Inwards DJ, Shah K, Ziesmer SC, Feldman AL, Rao R, Gupta M, et al.

(3) A new cytosolic pathway from a Parkinson disease-associated kinase, BRPK/PINK1: activation of AKT via mTORC2The Journal of biological chemistryMarch 4, 2011Murata H, Sakaguchi M, Jin Y, Sakaguchi Y, Futami J, Yamada H, Kataoka K, Huh NH.

(4) Rapamycin inhibits cytoskeleton reorganization and cell motility by suppressing RhoA expression and activityThe Journal of biological chemistryDecember 3, 2010Liu L, Luo Y, Chen L, Shen T, Xu B, Chen W, Zhou H, Han X, Huang S.

(7) The mTORC2 complex regulates terminal differentiation of C2C12 myoblastsMolecular and cellular biologySeptember 1, 2009Shu L, Houghton PJ.

(8) Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycinCancer researchAugust 1, 2009Yu K, Toral-Barza L, Shi C, Zhang WG, Lucas J, Shor B, Kim J, Verheijen J, Curran K, Malwitz DJ, et al.

(11) An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1The Journal of biological chemistryMarch 20, 2009Thoreen CC, Kang SA, Chang JW, Liu Q, Zhang J, Gao Y, Reichling LJ, Sim T, Sabatini DM, Gray NS.

(12) The insulin/Akt signaling pathway is targeted by intracellular beta-amyloidMolecular biology of the cellMarch 1, 2009Lee HK, Kumar P, Fu Q, Rosen KM, Querfurth HW.

(14) Curcumin disrupts the Mammalian target of rapamycin-raptor complexCancer researchFebruary 1, 2009Beevers CS, Chen L, Liu L, Luo Y, Webster NJ, Huang S.

(16) Isolation of hyperactive mutants of mammalian target of rapamycinThe Journal of biological chemistryNovember 14, 2008Ohne Y, Takahara T, Hatakeyama R, Matsuzaki T, Noda M, Mizushima N, Maeda T.

(17) Mitochondrial metabolism modulates differentiation and teratoma formation capacity in mouse embryonic stem cellsThe Journal of biological chemistryOctober 17, 2008Schieke SM, Ma M, Cao L, McCoy JP Jr, Liu C, Hensel NF, Barrett AJ, Boehm M, Finkel T.

(20) The TSC1-TSC2 complex is required for proper activation of mTOR complex 2Molecular and cellular biologyJune 1, 2008Huang J, Dibble CC, Matsuzaki M, Manning BD.

Rictor Antibody - BSA Free from Novus Biologicals, a Bio-Techne Brand